Viewing data from:

RISPERIDONE

ANDA

RISPERIDONE | A214068 | TEVA PHARMACEUTICALS USA INC

4 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: RISPERDAL CONSTA(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$812.38

per ea

Lowest NADAC/Unit

$369.64

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00480145308RISPERIDONE ER 50 MG VIAL	$812.38	EA	Generic	—	2026-06-17
00480134208RISPERIDONE ER 37.5 MG VIAL	$565.91	EA	Generic	—	2026-06-17
00480123208RISPERIDONE ER 25 MG VIAL	$369.64	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 4 NDCs (4 FSS)

Lowest Price

$192.54

Highest Price

$768.87

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00480-1232-08RISPERIDONE 25MG/VIL INJ,SUSP,SA	$384.43	FSS	AvKare, LLC	06/14/2028
00480-1342-08RISPERIDONE 37.5MG/VIL INJ,SUSP,SA	$576.83	FSS	AvKare, LLC	06/14/2028
00480-1453-08RISPERIDONE 50MG/VIL INJ,SUSP,SA	$768.87	FSS	AvKare, LLC	06/14/2028
00480-1554-08RISPERIDONE 12.5MG/VIL INJ,SUSP,SA	$192.54	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain18 active DMFs14 inactive

17 active API suppliers hold Drug Master Files for this ingredient.

JANSSEN PHARMACEUTICA NVRISPERIDONE (R064766) DRUG SUBSTANCE

DMF 114381995

TAPI NL BVRISPERIDONE USP

DMF 156042001

INKE SARISPERIDONE

DMF 156822001

DR REDDYS LABORATORIES LTDRISPERIDONE FORM-1 USP

DMF 169022003

CIPLA LTDRISPERIDONE USP

DMF 169632003

MATRIX PHARMACORP PRIVATE LTDRISPERIDONE USP

DMF 175202004

ZYDUS LIFESCIENCES LTDRISPERIDONE USP

DMF 180682005

APITORIA PHARMA PRIVATE LTDRISPERIDONE USP

DMF 181202005

INTERQUIM SARISPERIDONE

DMF 182572005

ZHEJIANG HUAHAI PHARMACEUTICAL CO LTDRISPERIDONE USP

DMF 205182007

SUN PHARMACEUTICAL INDUSTRIES LTDRISPERIDONE USP

DMF 214462008

TORRENT PHARMACEUTICALS LTDRISPERIDONE

DMF 216302008

IPCA LABORATORIES LTDRISPERIDONE USP

DMF 229112009

WUXI JIDA PHARMACEUTICAL CO LTDRISPERIDONE

DMF 256052011

TAPI NL BVRISPERIDONE STERILE

DMF 354342021

CHIERON ACTIVE INGREDIENTS PRIVATE LTDRISPERIDONE

DMF 356462021

ICROM SRLRISPERIDONE

DMF 359742021

STHREE CHEMICALS PRIVATE LTDRISPERIDONE USP

DMF 415792025

DR REDDYS LABORATORIES LTDInactiveRISPERIDONE EP

DMF 160232002

MEDICHEM SAInactiveRISPERIDONE

DMF 165162003

CATALENT PHARMA SOLUTIONS LLCInactiveRISPERIDONE 0.5 MG AND 1.0 MG ORALLY DISINTEGRATING TABLETS

DMF 169782003

CATALENT PHARMA SOLUTIONS LLCInactiveRISPERIDONE 2.0 MG ORALLY DISINTEGRATING TABLETS

DMF 172602004

GEDEON RICHTER LTDInactiveRISPERIDONE

DMF 184462005

LUPIN LTDInactiveRISPERIDONE USP

DMF 192672006

ERREGIERRE SPAInactiveRISPERIDONE PH. EUR.

DMF 193702006

WANBURY LTDInactiveRISPERIDONE

DMF 204092007

JIANGSU JIWA RINTECH PHARMACEUTICAL CO LTDInactiveRISPERIDONE EP, NON-STERILE DRUG SUBSTANCE

DMF 206562007

RPG LIFE SCIENCES LTDInactiveRISPERIDONE USP

DMF 224322009

APOTEX PHARMACHEM INDIA PVT LTDInactiveRISPERIDONE USP

DMF 228532009

QILU PHARMACEUTICAL CO LTDInactiveRISPERIDONE (NON STERILE, API)

DMF 242902010

QILU PHARMACEUTICAL CO LTDInactiveRISPERIDONE PROCESS II (NON STERILE, API)

DMF 252022011

ICROM SPAInactiveRISPERIDONE

DMF 256832011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (4)

Sort:

#001 — 12.5MG/VIAL

0 patents0 exclusivities▴

POWDER;INTRAMUSCULAR | Approved: Dec 5, 2023

No patent or exclusivity listings for this strength.

#002 — 25MG/VIAL

0 patents0 exclusivities▾

POWDER;INTRAMUSCULAR | Approved: Dec 5, 2023

#003 — 37.5MG/VIAL

0 patents0 exclusivities▾

POWDER;INTRAMUSCULAR | Approved: Dec 5, 2023

#004 — 50MG/VIAL

0 patents0 exclusivities▾

POWDER;INTRAMUSCULAR | Approved: Dec 5, 2023